<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04550819</url>
  </required_header>
  <id_info>
    <org_study_id>X20200703</org_study_id>
    <nct_id>NCT04550819</nct_id>
  </id_info>
  <brief_title>Intraintestinal Extended Biliary Stents Preventing Duodenobiliary Reflux in Patients With Biliary Stricture</brief_title>
  <official_title>Prevention of Duodenobiliary Reflux Via Intraintestinal Extended Biliary Stents in Patients With Biliary Stricture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metal or plastic biliary stents placement under Endoscopic Retrograde&#xD;
      Cholangiopancreatography(ERCP) is a well-established treatment for patients with benign&#xD;
      biliary obstruction to relieve jaundice, a palliative treatment for patients with&#xD;
      unresectable malignant pancreaticobiliary obstruction and a bridge to surgery for patients&#xD;
      with resectable disease. The main limitation of long time plastic stents is stents occlusion.&#xD;
      Biliary plastic stents are changed every 2 to 3 months due to an expected median patency from&#xD;
      77 to 126 days.Metal stents present a lower risk of recurring biliary occlusion, yet high&#xD;
      cost and stents occlusion are eventually inevitable. The mechanism of biliary stents&#xD;
      occlusion include biliary sludge of the accumulation of bacteria and duodenal biliary reflux&#xD;
      .The anti-reflux barrier of Oddi's sphincter disappears after the insertion of biliary stents&#xD;
      and the pressure in bile duct lowers the duodenale, which cause the retrograde flow of&#xD;
      duodenal material into the biliary ducts. Besides, ordinary biliary plastic stent is short&#xD;
      which can also shortens the length of duodenal biliary reflux . Therefore, trying to prevent&#xD;
      the duodenal biliary reflux is very important in reducing biliary stents occlusion and it is&#xD;
      gradually concerned by clinical researchers. Some studies have showed that plastic stents&#xD;
      with antireflux valves can effectively reduce the biliary stent stricture and prolong the&#xD;
      stents patency, which means reducing duodenobiliary reflux is surely useful for keeping&#xD;
      biliary stent patency.So,we assume to explore an innovatively intraintestinal extended&#xD;
      biliary stents (reformed with nasobiliary tube ) as substitution for ordinary biliary plastic&#xD;
      stent to prevent the duodenobiliary reflux by extending the length of duodenal content reflux&#xD;
      and avoid the stents shift via suspending in intrahepatic duct. In this study,we will design&#xD;
      a multicenter stratified randomized controlled trial to compare the patency of&#xD;
      intraintestinal extended biliary stents and ordinary plastic biliary stents in patients with&#xD;
      malignant or benign biliary obstruction respectively and evaluate the effect of&#xD;
      intraintestinal extended biliary stents for the prevention of duodenobiliary reflux.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Metal or plastic biliary stents placement under ERCP is a well-established treatment for&#xD;
      patients with benign biliary obstruction to relieve jaundice, a palliative treatment for&#xD;
      patients with unresectable malignant pancreaticobiliary obstruction and a bridge to surgery&#xD;
      for patients with resectable disease. Single or multiple plastic stents are recommended for&#xD;
      patients with benign stricture of the common bile duct or malignant stricture if the expected&#xD;
      survival is less than 4 months. The main limitation of long time plastic stents is stents&#xD;
      occlusion. Biliary plastic stents are changed every 2 to 3 months due to an expected median&#xD;
      patency from 77 to 126 days.Metal stents present a lower risk of recurring biliary occlusion,&#xD;
      yet high cost and stents occlusion are eventually inevitable. The mechanism of biliary stents&#xD;
      occlusion include biliary sludge of the accumulation of bacteria and duodenal biliary reflux&#xD;
      .The anti-reflux barrier of Oddi's sphincter disappears after the insertion of biliary stents&#xD;
      and the pressure in bile duct lowers the duodenale, which cause the retrograde flow of&#xD;
      duodenal material into the biliary ducts. Besides, ordinary biliary plastic stent is short&#xD;
      which can also shortens the length of duodenal biliary reflux . Therefore, trying to prevent&#xD;
      the duodenal biliary reflux is very important in reducing biliary stents occlusion and it is&#xD;
      gradually concerned by clinical researchers. Some studies have showed that plastic stents&#xD;
      with antireflux valves can effectively reduce the biliary stent stricture and prolong the&#xD;
      stents patency, which means reducing duodenobiliary reflux is surely useful for keeping&#xD;
      biliary stent patency.So,we assume to explore an innovatively intraintestinal extended&#xD;
      biliary stents with length of 26cm (reformed with nasobiliary tube ) as substitution for&#xD;
      ordinary biliary plastic stent to prevent the duodenobiliary reflux by extending the length&#xD;
      of duodenal content reflux and avoid the stents shift via suspending in intrahepatic duct. In&#xD;
      this study,we will design a multicenter stratified randomized controlled trial to compare the&#xD;
      patency of intraintestinal extended biliary stents and ordinary plastic biliary stents in&#xD;
      patients with malignant or benign biliary obstruction respectively and evaluate the effect of&#xD;
      intraintestinal extended biliary stents for the prevention of duodenobiliary reflux.&#xD;
&#xD;
      This prospective study will be performed at 6 tertiary hospitals in China.The investigators&#xD;
      will recruit patients according to admission criteria and exclusion criteria.The patients&#xD;
      stratified by malignant and benign biliary obstruction will be randomized (at a 1:1 ratio) to&#xD;
      intraintestinal extended biliary stents group (experimental group) and ordinary plastic&#xD;
      biliary stents group (control group).The experimental groups will be placed the&#xD;
      intraintestinal extended biliary stents in intrahepatic bile duct in ERCP. The control group&#xD;
      will be placed ordinary plastic biliary stents in ERCP. The primary endpoint is the duration&#xD;
      of stent patency and the rate of stent occlusion.The secondary outcomes include the mortality&#xD;
      of each group、adverse events and the rate of technical success.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the duration of stent patency and stent occlusion rate</measure>
    <time_frame>12 months after ERCP</time_frame>
    <description>Patients with symptoms of cholangitis and worsening liver function tests suggestive of cholestasis are considered as premature stent occlusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality of each group</measure>
    <time_frame>12 months after ERCP</time_frame>
    <description>We will compare the mortality of each group after the insertion of biliary stents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>12 months after ERCP</time_frame>
    <description>Adverse events include complications of post ERCP such as pancreatitis,biliary infection, bleeding, perforation，and stent migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of technical success</measure>
    <time_frame>12 months after ERCP</time_frame>
    <description>Technical success is defined as successful insertion of the stent into the bile duct during ERCP</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">724</enrollment>
  <condition>Bile Duct Stricture</condition>
  <arm_group>
    <arm_group_label>IEBSs in malignant extrahepatic biliary stricture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraintestinal extended biliary stents(IEBSs) in patients with malignant extrahepatic biliary stricture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPBSs in malignant extrahepatic biliary stricture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional plastic biliary stents(CPBSs) in patients with malignant extrahepatic biliary stricture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IEBSs in benign extrahepatic biliary stricture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraintestinal extended biliary stents(IEBSs) in patients with benign extrahepatic biliary stricture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPBSs in benign extrahepatic biliary stricture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional plastic biliary stents(CPBSs) in patients with benign extrahepatic biliary stricture</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intraintestinal extended biliary stents</intervention_name>
    <description>The test group will be placed intraintestinal extended biliary stents in intrahepatic bile duct in ERCP</description>
    <arm_group_label>IEBSs in benign extrahepatic biliary stricture</arm_group_label>
    <arm_group_label>IEBSs in malignant extrahepatic biliary stricture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ordinary plastic biliary stents</intervention_name>
    <description>The test group will be placed ordinary plastic biliary stents in intrahepatic bile duct in ERCP</description>
    <arm_group_label>CPBSs in benign extrahepatic biliary stricture</arm_group_label>
    <arm_group_label>CPBSs in malignant extrahepatic biliary stricture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Malignant or benign extrahepatic biliary stricture,available for insertion of biliary&#xD;
             stents in ERCP to alleviate biliary stricture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with malignant or benign biliary stricture do not agree with endoscopic&#xD;
             treatment&#xD;
&#xD;
          -  Patients agree with metal biliary stents&#xD;
&#xD;
          -  Patients with resectable biliary occlusion&#xD;
&#xD;
          -  A guidewire could not be passed through the stricture&#xD;
&#xD;
          -  Patients with an expected life survival &lt;3months&#xD;
&#xD;
          -  Patients with duodenal obstruction and duodenal endoscopy could not be reached to&#xD;
             papillary&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yonghui Huang, archiater</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yonghui Huang, archiater</last_name>
    <phone>13911765322</phone>
    <email>xuxiao_1028@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Dumonceau JM, Tringali A, Blero D, Devière J, Laugiers R, Heresbach D, Costamagna G; European Society of Gastrointestinal Endoscopy. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012 Mar;44(3):277-98. doi: 10.1055/s-0031-1291633. Epub 2012 Feb 1.</citation>
    <PMID>22297801</PMID>
  </reference>
  <reference>
    <citation>Libby ED, Leung JW. Prevention of biliary stent clogging: a clinical review. Am J Gastroenterol. 1996 Jul;91(7):1301-8. Review.</citation>
    <PMID>8677983</PMID>
  </reference>
  <reference>
    <citation>van Berkel AM, Boland C, Redekop WK, Bergman JJ, Groen AK, Tytgat GN, Huibregtse K. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy. 1998 Oct;30(8):681-6.</citation>
    <PMID>9865556</PMID>
  </reference>
  <reference>
    <citation>van Berkel AM, Bruno MJ, Bergman JJ, van Deventer SJ, Tytgat GN, Huibregtse K. A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction. Endoscopy. 2003 Jun;35(6):478-82.</citation>
    <PMID>12783344</PMID>
  </reference>
  <reference>
    <citation>Reddy DN, Banerjee R, Choung OW. Antireflux biliary stents: are they the solution to stent occlusions? Curr Gastroenterol Rep. 2006 Apr;8(2):156-60. Review.</citation>
    <PMID>16533479</PMID>
  </reference>
  <reference>
    <citation>van Berkel AM, van Marle J, van Veen H, Groen AK, Huibregtse K. A scanning electron microscopic study of biliary stent materials. Gastrointest Endosc. 2000 Jan;51(1):19-22.</citation>
    <PMID>10625789</PMID>
  </reference>
  <reference>
    <citation>Groen AK, Out T, Huibregtse K, Delzenne B, Hoek FJ, Tytgat GN. Characterization of the content of occluded biliary endoprostheses. Endoscopy. 1987 Mar;19(2):57-9.</citation>
    <PMID>3106022</PMID>
  </reference>
  <reference>
    <citation>Speer AG, Cotton PB, Rode J, Seddon AM, Neal CR, Holton J, Costerton JW. Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Ann Intern Med. 1988 Apr;108(4):546-53.</citation>
    <PMID>2450501</PMID>
  </reference>
  <reference>
    <citation>Liu YF, Saccone GT, Thune A, Baker RA, Harvey JR, Toouli J. Sphincter of Oddi regulates flow by acting as a variable resistor to flow. Am J Physiol. 1992 Nov;263(5 Pt 1):G683-9.</citation>
    <PMID>1443142</PMID>
  </reference>
  <reference>
    <citation>Donelli G, Guaglianone E, Di Rosa R, Fiocca F, Basoli A. Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res. 2007 Mar;5(1):53-60. Review.</citation>
    <PMID>17456835</PMID>
  </reference>
  <reference>
    <citation>van Berkel AM, van Marle J, Groen AK, Bruno MJ. Mechanisms of biliary stent clogging: confocal laser scanning and scanning electron microscopy. Endoscopy. 2005 Aug;37(8):729-34.</citation>
    <PMID>16032491</PMID>
  </reference>
  <reference>
    <citation>Dua KS, Reddy ND, Rao VG, Banerjee R, Medda B, Lang I. Impact of reducing duodenobiliary reflux on biliary stent patency: an in vitro evaluation and a prospective randomized clinical trial that used a biliary stent with an antireflux valve. Gastrointest Endosc. 2007 May;65(6):819-28. Epub 2007 Mar 26.</citation>
    <PMID>17383650</PMID>
  </reference>
  <reference>
    <citation>Vihervaara H, Grönroos JM, Hurme S, Gullichsen R, Salminen P. Antireflux Versus Conventional Plastic Stent in Malignant Biliary Obstruction: A Prospective Randomized Study. J Laparoendosc Adv Surg Tech A. 2017 Jan;27(1):53-57. doi: 10.1089/lap.2016.0178. Epub 2016 Oct 18.</citation>
    <PMID>27754790</PMID>
  </reference>
  <reference>
    <citation>Yang F, Ren Z, Chai Q, Cui G, Jiang L, Chen H, Feng Z, Chen X, Ji J, Zhou L, Wang W, Zheng S. A novel biliary stent coated with silver nanoparticles prolongs the unobstructed period and survival via anti-bacterial activity. Sci Rep. 2016 Feb 17;6:21714. doi: 10.1038/srep21714.</citation>
    <PMID>26883081</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>October 9, 2020</last_update_submitted>
  <last_update_submitted_qc>October 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Third Hospital</investigator_affiliation>
    <investigator_full_name>Huang Yonghui</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

